-
Je něco špatně v tomto záznamu ?
A "cute" desensitization of TRPV1
F. Touska, L. Marsakova, J. Teisinger, V. Vlachova,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- analgetika metabolismus farmakologie MeSH
- fosfolipasa C fosfoinositidové signalizace metabolismus MeSH
- fosforylace MeSH
- kapsaicin metabolismus farmakologie MeSH
- kationtové kanály TRPV agonisté metabolismus MeSH
- lidé MeSH
- nociceptory metabolismus MeSH
- vápník metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Capsaicin and other vanilloids selectively excite and subsequently desensitize pain-conducting nerve fibers (nociceptors) and this process contributes to the analgesic (and thus therapeutically relevant) effects of these compounds. Such a desensitization process is triggered by the activation of the transient receptor potential vanilloid subtype 1 receptor channels (TRPV1) that open their cationic pores, permeable to sodium, potassium and calcium (Ca(2+)) ions. Depending on the duration of capsaicin exposure and the external calcium concentration, the Ca(2+) influx via TRPV1 channels desensitizes the channels themselves, which, from the cellular point of view, represents a feedback mechanism protecting the nociceptive neuron from toxic Ca(2+) overload. The 'acute desensitization' accounts for most of the reduction in responsiveness occurring within the first few (~20) seconds after the vanilloids are administered to the cell for the first time. Another form of desensitization is 'tachyphylaxis', which is a reduction in the response to repeated applications of vanilloid. The wealth of pathways following TRPV1 activation that lead to increased intracellular Ca(2+) levels and both forms of desensitization is huge and they might utilise just about every known type of signalling molecule. This review will not attempt to cover all historical aspects of research into all these processes. Instead, it will try to highlight some new challenging thoughts on the important phenomenon of TRPV1 desensitization and will focus on the putative mechanisms that are thought to account for the acute phase of this process.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12027958
- 003
- CZ-PrNML
- 005
- 20160211100424.0
- 007
- ta
- 008
- 120817s2011 ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.2174/138920111793937826 $2 doi
- 035 __
- $a (PubMed)20932251
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Touška, Filip $7 xx0121543 $u Department of Cellular Neurophysiology, Institute of Physiology, Academy of Sciences of the Czech Republic, Videnska 1083, 142 20 Prague 4, Czech Republic.
- 245 13
- $a A "cute" desensitization of TRPV1 / $c F. Touska, L. Marsakova, J. Teisinger, V. Vlachova,
- 520 9_
- $a Capsaicin and other vanilloids selectively excite and subsequently desensitize pain-conducting nerve fibers (nociceptors) and this process contributes to the analgesic (and thus therapeutically relevant) effects of these compounds. Such a desensitization process is triggered by the activation of the transient receptor potential vanilloid subtype 1 receptor channels (TRPV1) that open their cationic pores, permeable to sodium, potassium and calcium (Ca(2+)) ions. Depending on the duration of capsaicin exposure and the external calcium concentration, the Ca(2+) influx via TRPV1 channels desensitizes the channels themselves, which, from the cellular point of view, represents a feedback mechanism protecting the nociceptive neuron from toxic Ca(2+) overload. The 'acute desensitization' accounts for most of the reduction in responsiveness occurring within the first few (~20) seconds after the vanilloids are administered to the cell for the first time. Another form of desensitization is 'tachyphylaxis', which is a reduction in the response to repeated applications of vanilloid. The wealth of pathways following TRPV1 activation that lead to increased intracellular Ca(2+) levels and both forms of desensitization is huge and they might utilise just about every known type of signalling molecule. This review will not attempt to cover all historical aspects of research into all these processes. Instead, it will try to highlight some new challenging thoughts on the important phenomenon of TRPV1 desensitization and will focus on the putative mechanisms that are thought to account for the acute phase of this process.
- 650 _2
- $a analgetika $x metabolismus $x farmakologie $7 D000700
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a vápník $x metabolismus $7 D002118
- 650 _2
- $a kapsaicin $x metabolismus $x farmakologie $7 D002211
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nociceptory $x metabolismus $7 D009619
- 650 _2
- $a fosfolipasa C fosfoinositidové signalizace $x metabolismus $7 D054801
- 650 _2
- $a fosforylace $7 D010766
- 650 _2
- $a kationtové kanály TRPV $x agonisté $x metabolismus $7 D050916
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Maršáková, Lenka. $7 _AN066948
- 700 1_
- $a Teisinger, Jan, $d 1944- $7 xx0088476
- 700 1_
- $a Vlachová, Viktorie, $d 1958- $7 xx0030589
- 773 0_
- $w MED00007892 $t Current pharmaceutical biotechnology $x 1873-4316 $g Roč. 12, č. 1 (2011), s. 122-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20932251 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20160211100604 $b ABA008
- 999 __
- $a ok $b bmc $g 950000 $s 785304
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 12 $c 1 $d 122-9 $i 1873-4316 $m Current pharmaceutical biotechnology $n Curr Pharm Biotechnol $x MED00007892
- LZP __
- $a Pubmed-20120817/11/03